Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Azacitidine × 30 days × Clear all

Phase

Phase 2 24 Phase 1 15 Phase 1/2 12 Phase 3 4 Phase 2/3 3 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Prednisone 3 enzalutamide 2 Injections 2 HMPL-013 2 Dexamethasone 2 Cisplatin 2 Carboplatin 2 Cannabidiol 2 zanubrutinib 1 trastuzumab deruxtecan 1 trastuzumab biosimilar HLX02 1 toripalimab 1 testosterone 17 beta-cypionate 1 talquetamab 1 suvorexant 1 sofosbuvir-velpatasvir drug combination 1 ruxolitinib 1 rozanolixizumab 1 ribociclib 1 relatlimab 1 ravulizumab 1 pirtobrutinib 1 pembrolizumab 1 obinutuzumab 1 nirogacestat 1 niraparib 1 nilotinib 1 lenvatinib 1 ibrutinib 1 human papillomavirus vaccine, L1 type 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06370000 2026-03-02

REMAIN1

Virginia Commonwealth University

Phase 4 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡